Overview
The PRECISEU Open Call is a cascade funding opportunity under Horizon Europe HORIZON-EIE to support interregional innovation projects in personalised medicine, focusing on ATMPs and health data solutions at TRL 6–8. The total budget is €11,570,000 delivered as grants via a cascade funding (FSTP) mechanism. Eligible proposals must be joint interregional projects with at least three independent entities from three different PRECISEU funding territories (examples: Baden-Württemberg, Castilla La Mancha, Catalonia, Crete, Emilia‑Romagna, Ireland, Lazio, Lithuania, North East Romania) and include at least one SME. The call opened on 13 April 2026 with a single-stage submission deadline of 14 June 2026 (17:00 Brussels time) via the PRECISEU submission system and applicants must consult the Call text, Guide for Applicants and regional annexes for detailed rules.
Partner Search
Find collaboration partners for this call
What You Offer
Describe your expertise here...
You Are Looking For
Describe what you seek here...
Highlights
What it funds
Scope
Cascade funding for interregional innovation projects (Joint Interregional Projects) in personalised medicine. Priority areas include advanced therapy medicinal products ATMPs and health data solutions, targeting TRL 6–8 or equivalent to accelerate uptake and scale-up across regional ecosystems.
Total budget and key dates:Total available: €11,570,000. Opening date: 13 April 2026. Submission deadline: 14 June 2026, 17:00 Brussels time.
Who can apply
Consortia and applicants from participating regions including SMEs, startups, research organisations and other innovation actors. Projects must be interregional and comply with regional annexes and funding agency requirements.
- 1Eligible applicants: SMEs, startups, innovation actors, research organisations in participating regions
- 2Project focus: Personalised medicine, ATMPs, health data; TRL 6–8
- 3Application route: Submit via PRECISEU submission system and follow Guide for Applicants and Terms & Conditions
Participating territories (examples)
| Country / Region | Examples |
|---|---|
| Germany | Baden-Württemberg |
| Spain | Catalonia; Castilla La Mancha |
| Italy | Emilia-Romagna; Lazio |
| Other | Crete (Greece); Ireland; Lithuania; North East (Romania) |
Evaluation is by an independent panel using the PRECISEU evaluation criteria. Applicants should consult the Call text, regional annexes and Guide for Applicants for eligibility, funding modalities and scoring. Contact and submission details are available on the PRECISEU website PRECISEU Open Call 1.
Footnotes
- 1Full call documents, application templates, regional annexes and access to the submission system are provided on the PRECISEU website and in the Guide for Applicants: PRECISEU Funding page; general helpdesk: preciseu@biocat.cat.
Find a Consultant to Support You
Breakdown
Opportunity Title:PRECISEU Open Call. Call Type: Multi-Topic Call, Cascade funding (FSTP) under the PRECISEU project. Opening date: 13 April 2026. Deadline (single-stage): 14 June 2026 17:00 Brussels time. Total funding available: €11,570,000. Grant agreement number: 101161301. HORIZON-EIE Implementing co-funded action plans for connected regional innovation valleys.
Purpose and scope
The general objective of the PRECISEU Open Call is to support interregional innovation projects in personalised medicine that foster collaboration across European regions and accelerate uptake of innovative solutions. The call targets projects typically in Technology Readiness Levels 6 to 8 or equivalent, focusing on the development, validation, demonstration and early market uptake of deep-tech healthcare innovations. The PRECISEU programme emphasises advanced therapy medicinal products ATMPs, health data solutions, patient-centred innovations and strengthening regional innovation ecosystems under the Regional Innovation Valleys framework.
What PRECISEU provides and applicant support
PRECISEU provides cascade funding to successful applicants and an enabling package consisting of: access to the submission system through the PRECISEU website; a Guide for Applicants; PRECISEU Terms and Conditions; Call text and application templates; regional annexes detailing local funding agency requirements; infoday and regional webinars; regional contact points for eligibility and funding questions; a general helpdesk at preciseu@biocat.cat; and a PRECISEU Matchmaking Platform to connect stakeholders across participating regions.
Eligible Applicant Types:SMEs, startups, research organisations such as universities and research institutes, innovation actors and intermediaries within regional ecosystems, nonprofits and other organisations active in healthcare innovation. The call explicitly empowers SMEs and startups and invites participation by regional innovation actors; public authorities or larger enterprises may be involved as partners depending on regional funding rules specified in regional annexes.
Funding Type:Cascade funding (first-stage technology preparedness funding — FSTP) delivered as grants to selected interregional Joint Interregional Projects (JIPs).
Consortium Requirement:The call supports joint interregional projects, therefore consortia spanning participating PRECISEU regions are expected. Exact consortium composition, minimum number of legal entities and lead beneficiary rules are defined in the Call text and regional/national annexes; applicants must consult these documents to verify specific mandatory consortium structures for their proposal.
Beneficiary Scope (Geographic Eligibility):The call targets applicants from PRECISEU funding territories. Explicitly mentioned participating regions and countries are: Baden-Württemberg (Germany); Castilla La Mancha (Spain); Catalonia (Spain); Crete (Greece); Emilia-Romagna (Italy); Ireland (country-level); Lazio (Italy); Lithuania (country-level); North East (Romania). Applicants from these territories should consult regional annexes for local eligibility and funding agency requirements. Projects should be interregional, involving partners from two or more of the participating territories.
Target Sector:Personalised medicine, with priority topics including advanced therapy medicinal products ATMPs, health data solutions and patient-centred healthcare innovations. The call aims to strengthen digital and sustainable transformation of healthcare systems and the scaling of deep-tech healthcare innovations.
Project Stage:Targeted maturity: development, validation, demonstration and early commercialisation — typically TRL 6 to 8 or equivalent. Projects should be beyond idea stage and ready for demonstration, validation in relevant environments and preparation for market uptake.
Funding Amount:Total call budget €11,570,000. Individual award sizes, maximum per project, and co-funding rules are specified in the Call text and regional annexes; applicants must consult those documents for the exact funding range per project and per beneficiary.
Application Type and Submission:Open call with a single-stage submission. Applicants must submit proposals using the dedicated submission system available through the PRECISEU website. Required documents include the application form template and any regional annex forms as provided by PRECISEU. Infoday and regional webinars will be offered to support applicants.
Nature of Support:Financial support in the form of grants (cascade funding). Non-financial support includes matchmaking, webinars, guidance documents, a helpdesk and access to the PRECISEU ecosystem services aimed at proposal development and ecosystem strengthening.
Application Stages and Evaluation:Single-stage submission. Submitted proposals will be evaluated by an independent panel of external experts against published evaluation criteria in the PRECISEU Terms and Conditions and the Guide for Applicants. Applicants are strongly encouraged to follow the Guide for Applicants, Call text and regional annexes to ensure compliance with eligibility and assessment rules.
Success Rates:No call-level success rate is provided in the available material. Success rates will depend on number and quality of applications and regional allocation rules. Applicants should assume competitive selection and prepare high-quality, regionally aligned proposals.
Co-funding Requirement:Co-funding expectations and rules are region-specific and detailed in the regional annexes. Some regional funding agencies may require co-funding or set maximum funding rates per beneficiary. Applicants must check regional annexes and the Call text to confirm whether co-funding by applicants or third parties is required for their region.
Templates and Application Structure:PRECISEU provides the full set of call documents, including the Call text, application templates and regional annexes on the PRECISEU website. Typical template components to expect: project summary; consortium description and letters of support; work plan with tasks, milestones and deliverables; Gantt or timeline; budget table by beneficiary and cost categories; description of impact, exploitation and dissemination; ethics and data management compliance; regional eligibility declarations. Applicants must use the official application templates available on the PRECISEU website and complete any region-specific annex forms.
Evaluation and compliance notes
Submitted proposals will be evaluated against the evaluation criteria published in the Terms and Conditions and Guide for Applicants. Compliance with PRECISEU framework rules, regional eligibility and specific funding agency requirements is mandatory. Applicants are strongly advised to consult the Guide for Applicants, Call text and regional annexes and to use the PRECISEU Matchmaking Platform and regional contact points for alignment and to clarify questions prior to submission.
- 1Opening date: 13 April 2026
- 2Deadline: 14 June 2026, 17:00 (Brussels time), single-stage
- 3Total funding: €11,570,000
- 4Target TRL: 6–8 (development, validation, demonstration, early uptake)
- 5Participating territories: Baden-Württemberg, Castilla La Mancha, Catalonia, Crete, Emilia-Romagna, Ireland, Lazio, Lithuania, North East Romania
- 6Submission: via PRECISEU submission system on the PRECISEU website
- 7Support: Guide for Applicants, Terms and Conditions, regional annexes, webinars, matchmaking platform, helpdesk preciseu@biocat.cat
| Participating region / country | Notes |
|---|---|
| Baden-Württemberg (Germany) | Regional partner; consult regional annex for national funding rules |
| Castilla La Mancha (Spain) | Regional partner; consult regional annex for national funding rules |
| Catalonia (Spain) | Regional partner; contact regional contact point for eligibility |
| Crete (Greece) | Regional partner; consult regional annex |
| Emilia-Romagna (Italy) | Regional partner; consult regional annex |
| Ireland | Country-level participation; consult regional annex for national rules |
| Lazio (Italy) | Regional partner; consult regional annex |
| Lithuania | Country-level participation; consult regional annex |
| North East (Romania) | Regional partner; consult regional annex |
For further detailed official documents, templates and submission portal access consult the PRECISEU website and Call page. The PRECISEU Matchmaking Platform is recommended for finding partners across participating regions. For queries contact preciseu@biocat.cat PRECISEU website PRECISEU call page on EU portal.
This summary is based on the PRECISEU Open Call published materials including the Call text, Guide for Applicants, Terms and Conditions and regional annexes as available on the PRECISEU website and the EU Funding & Tenders Portal. Applicants must consult the official call documentation for definitive rules, templates, and funding conditions 1.
Footnotes
- 1Official call documents, templates, regional annexes and submission portal are available on the PRECISEU website and the EU Funding & Tenders Portal: preciseu.eu and ec.europa.eu
Short Summary
Impact Accelerate the development, validation and early market uptake of personalised medicine solutions—particularly ATMPs and health-data-driven innovations—by scaling them across European regional innovation ecosystems and ensuring regulatory readiness. | Impact | Accelerate the development, validation and early market uptake of personalised medicine solutions—particularly ATMPs and health-data-driven innovations—by scaling them across European regional innovation ecosystems and ensuring regulatory readiness. |
Applicant Teams with capability to advance technologies at TRL 6–8 (development, validation, demonstration), navigate regulatory pathways for health products, execute interregional collaboration, and prepare for early commercialisation and market uptake. | Applicant | Teams with capability to advance technologies at TRL 6–8 (development, validation, demonstration), navigate regulatory pathways for health products, execute interregional collaboration, and prepare for early commercialisation and market uptake. |
Developments Interregional projects in personalised medicine, with priority on advanced therapy medicinal products (ATMPs) and health-data solutions, targeting demonstration/validation and early market deployment (TRL 6–8). | Developments | Interregional projects in personalised medicine, with priority on advanced therapy medicinal products (ATMPs) and health-data solutions, targeting demonstration/validation and early market deployment (TRL 6–8). |
Applicant Type Profit SMEs/startups, researchers (universities and research organisations), large corporations, government organisations, and NGOs/non-profits. | Applicant Type | Profit SMEs/startups, researchers (universities and research organisations), large corporations, government organisations, and NGOs/non-profits. |
Consortium Designed for consortia:minimum three independent entities from three different PRECISEU funding regions, spanning at least two EU Member States, including at least one SME, with the coordinator established in a funding region. | Consortium | Designed for consortia:minimum three independent entities from three different PRECISEU funding regions, spanning at least two EU Member States, including at least one SME, with the coordinator established in a funding region. |
Funding Amount Total call budget €11,570,000; grants of up to €3,000,000 per project and a maximum of €600,000 per entity. | Funding Amount | Total call budget €11,570,000; grants of up to €3,000,000 per project and a maximum of €600,000 per entity. |
Countries Relevant participating territories include regions/countries such as Baden-Württemberg (Germany), Castilla‑La Mancha and Catalonia (Spain), Crete (Greece), Emilia‑Romagna and Lazio (Italy), Ireland, Lithuania, and North East (Romania); applicants must be established in these PRECISEU funding territories. | Countries | Relevant participating territories include regions/countries such as Baden-Württemberg (Germany), Castilla‑La Mancha and Catalonia (Spain), Crete (Greece), Emilia‑Romagna and Lazio (Italy), Ireland, Lithuania, and North East (Romania); applicants must be established in these PRECISEU funding territories. |
Industry Horizon Europe HORIZON-EIE cascade funding under the PRECISEU Regional Innovation Valleys initiative, targeting the personalised medicine / healthtech sector. | Industry | Horizon Europe HORIZON-EIE cascade funding under the PRECISEU Regional Innovation Valleys initiative, targeting the personalised medicine / healthtech sector. |
Additional Web Data
The PRECISEU Open Call is a cascade funding opportunity under the Horizon Europe programme, specifically HORIZON-EIE, aimed at supporting interregional innovation projects in personalised medicine. It fosters collaboration across European regions to accelerate the uptake of innovative solutions in advanced therapy medicinal products (ATMPs) and health data utilisation, typically at Technology Readiness Levels (TRL) 6-8.
The call is part of the PRECISEU project (PeRsonalised medicine Empowerment Connecting Innovation ecoSystems across EUrope), with grant agreement 101161301, coordinated by Biocat (Spain). Total funding available is €11,570,000, co-funded 50% by the EU and 50% by regional funding agencies.
Key Dates and Timeline
- 1Opening date: 13 April 2026
- 2Deadline: 14 June 2026 at 17:00 Brussels time (single-stage submission)
- 3Evaluation and results expected by 31 July 2026
- 4Project duration: October 2026 to March 2029 (approximately 30 months)
Note:An Expression of Interest (EoI) phase preceded the full call, running from 20 May to 31 July 2025, to support funneling, mentoring, and matchmaking. Info webinars and matchmaking events, such as on 14 April 2026 and 6 February 2026, are available to assist applicants.
Eligibility and Who Can Apply
Eligible applicants include SMEs, startups, research institutions, universities, hospitals, healthcare providers, public administrations, associations, NGOs, patient organisations, and large companies. Only entities established in PRECISEU funding territories can receive funding.
Funding Territories:Baden-Württemberg (Germany), Castilla La Mancha (Spain), Catalonia (Spain), Crete (Greece), Emilia-Romagna (Italy), Ireland, Lazio (Italy), Lithuania, North East (Romania).1
Consortium Requirements
- At least three independent entities from three different funding regions
- From at least two different EU Member States
- At least one SME
- Project coordinator must be established in one of the funding regions
Funding Details
| Total Budget | €11,570,000 |
|---|---|
| Max per Project | Up to €3,000,000 |
| Max per Entity | €600,000 |
| Funding Type | Grants via cascade funding (FSTP) |
| Focus Areas | ATMPs, health data for personalised medicine; TRL 6-8 progression with clear regulatory pathway to market |
Proposals must demonstrate interregional collaboration, innovation uptake, and alignment with regional strengths in personalised medicine. Evaluation by independent experts based on criteria in the Terms & Conditions.
Application Process
- 1Submit via dedicated system on the PRECISEU website (PRECISEU Funding Page).
- 2English only, single-stage process.
- 3Review Guide for Applicants, Call text, application templates, and regional/national annexes for compliance.
- 4Contact regional points or general helpdesk (preciseu@biocat.cat) for eligibility queries.
Additional support includes matchmaking platform (PRECISEU Matchmaking), infodays, regional webinars, and proposal preparation guidance. Primary source: EU Funding Portal.
Project Objectives and Expected Impact
Supports Joint Interregional Projects (JIPs) to connect ecosystems, transfer best practices, scale deep-tech innovations, and transform healthcare systems digitally and sustainably. Emphasises patient-centred solutions, regulatory readiness, and addressing disparities between high and low innovation performance regions.
Footnotes
- 1Full list from official metadata; some sources mention additional regions like Flanders or Rivne (Ukraine) for collaboration but not necessarily funding.
Update Log
No updates recorded yet.
Discover with AI
Let our intelligent agent help you find the perfect funding opportunities tailored to your needs.
EU Grant Database
Explore European funding opportunities in our comprehensive, up-to-date collection.
Stay Informed
Get notified when grants change, deadlines approach, or new opportunities match your interests.
Track Your Favorites
Follow grants you're interested in and keep them organized in one place. Get updates on changes and deadlines.
AIoD OC1-Private Sector
AIoD OC1-Private Sector is a cascade funding open call under the DeployAI project (Digital Europe) to accelerate integration and market deployment of mature European AI solutions (mandatory TRL 7+). Total budget is EUR 1,300,000 with up...
CR. EU. IN. HERITAGE: Cultural Heritage Innovation Grants
CR.EU.IN.HERITAGE funds SME-led collaborative innovation projects in the Cultural Heritage Value Chain to strengthen European strategic autonomy and support the green and digital transition. The total budget is EUR 1,970,000 with fixed l...
RENEW-BOOSTER EUROCLUSTER CALL N°1 FOR FINANCIAL SUPPORT TO THIRD PARTIES
RENEW-BOOSTER Eurocluster Call No.1 offers EUR 800,000 in cascade grants to support SMEs developing innovations in photovoltaics, offshore wind (including floating) and energy grids, with a per‑SME cap of EUR 60,000. The call is structur...
LLM-BRIDGE – Venture Incubation Programme - Open Call for Start-ups – 1st Call
The LLM-BRIDGE Venture Incubation Programme will select 30 early-stage startups working on Generative AI, LLMs, NLP or related technologies for a 12-week incubation in summer 2026. Selected startups will receive mentoring, technical guid...
PERIFORMANCE OPEN CALL FOR BOTTOM-UP STAKEHOLDER ENGAGEMENT INITIATIVES IN CANCER RESEARCH & CARE
PERIFORMANCE Open Call (Grant Agreement 101216808) provides cascade funding under Horizon Europe to support up to 15 bottom-up local or regional stakeholder engagement initiatives in cancer research and care across Europe. Total budget i...
Open Call for innovative projects enhancing the valorisation of agri-food biomass
The GRAPPA Open Call (Grant Agreement 101235085) provides cascade lump-sum grants to SMEs to develop, demonstrate and commercialise solutions that maximise valorisation of agri-food biomass and side-streams, prioritising upcycled ingredi...
GATE5.0 Open Call for Agrifood & Technology SMEs – Financial Support to Third Parties (FSTP)
GATE5.0 Open Call offers Financial Support to Third Parties (FSTP) to consortia composed of at least one Agrifood SME and one Technology SME to develop, validate and scale green and digital Agriculture 5.0 solutions. The single-stage cal...
Open Call 2 - Short Term and Long Term Funding to support ICT standardisation
StandICT.eu 2029 Open Call 2 offers cascade funding to support European standardisation specialists to contribute to international ICT standards development within Standards Development Organisations. The call opens 23 February 2026 and...
InnoMatch project - Open call 2 for EIC Awardees
InnoMatch Open Call 2 supports Horizon Europe EIC Awardees to pilot demand-driven solutions with committed public or private buyers through a Prepare, Deploy and Assess programme. The call will select 4 pilots in this wave, offering up t...
Scaleups Promotion Open Call
Scaleups Promotion Open Call (EITUM-BP26-28) is a cascade funding opportunity under the EIT Urban Mobility Business Plan 2026-2028 with total funding of EUR 415,000 to support strategic positioning of European urban mobility scaleups, in...
Multi-country Investigator-Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases (Trials4Health) JTC2026
The Trials4Health JTC2026 initiative announces a €32.19 million funding opportunity targeting multi-country Investigator-Initiated Clinical Studies focused on cardiovascular, metabolic, and autoimmune disorders. This program aims to enha...
Open Call 1 addressed to research and technology stakeholders
FCI4Africa Open Call 1 (Horizon Europe, Grant 101182485) provides cascade funding to single legal-entity research and technology stakeholders to test, validate and demonstrate innovations that strengthen trade, address non-tariff measure...